Simplex Trading
ORKA

Simplex Trading’s Oruka Therapeutics ORKA Stock Holding History

Simplex Trading’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-200
Closed -$6.06K – 10401
2025
Q4 		$6.06K Sell
200
-200
-50% -$5.57K ﹤0.01% 7320
2025
Q3 		$7K Buy
+400
New +$5.93K ﹤0.01% 8146
2025
Q2 		– Sell
-100
Closed -$1K – 9953
2025
Q1 		$1K Buy
+100
New +$1.25K ﹤0.01% 8348
2023
Q3 		– Sell
-108
Closed -$2K – 10056
2023
Q2 		$2K Sell
108
-1,184
-92% -$29.1K ﹤0.01% 8514
2023
Q1 		$30K Buy
+1,292
New +$34K ﹤0.01% 6501
2022
Q4 		– Sell
-233
Closed -$5K – 10673
2022
Q3 		$5K Sell
233
-667
-74% -$18.8K ﹤0.01% 8835
2022
Q2 		$26K Buy
900
+842
+1,452% +$23.8K ﹤0.01% 7314
2022
Q1 		$1K Buy
+58
New +$1.44K ﹤0.01% 10172
2021
Q4 		– Sell
-200
Closed -$8K – 11632
2021
Q3 		$8K Sell
200
-133
-40% -$4.92K ﹤0.01% 9079
2021
Q2 		$13K Buy
333
+329
+8,225% +$13.7K ﹤0.01% 8939
2021
Q1 		$17K Sell
4
-1
-20% -$52 ﹤0.01% 7599
2020
Q4 		$23K Buy
+5
New +$249 ﹤0.01% 6887

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Simplex Trading's ORKA Position: Q1 2026 in Review

Simplex Trading opened a new position in Oruka Therapeutics (ORKA) in Q1 2026: 2,463 shares worth $121K. The stake represents ﹤0.01% of the portfolio and ranks #4867 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ORKA as recently as Q3 2025.

Simplex Trading first reported a position in ORKA in Q4 2020 and has held it in 10 quarters since. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • Simplex Trading held 2,463 shares of Oruka Therapeutics worth $121K as of Q1 2026.
  • Oruka Therapeutics was a new Simplex Trading position in Q1 2026.
  • Oruka Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4867 holding.
  • Simplex Trading first reported a position in Oruka Therapeutics in Q4 2020 and has held it in 10 quarters since.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.